115 related articles for article (PubMed ID: 38873438)
1. Lipid- and glucose-lowering effects of Rhamnan sulphate from
Shimada Y; Zang L; Ishimaru T; Nishiura K; Matsuda K; Uchida R; Nakayama H; Matsuoka I; Terasawa M; Nishimura N
Food Sci Nutr; 2024 Jun; 12(6):4342-4352. PubMed ID: 38873438
[TBL] [Abstract][Full Text] [Related]
2. Rhamnan sulphate from green algae Monostroma nitidum improves constipation with gut microbiome alteration in double-blind placebo-controlled trial.
Shimada Y; Terasawa M; Okazaki F; Nakayama H; Zang L; Nishiura K; Matsuda K; Nishimura N
Sci Rep; 2021 Jul; 11(1):13384. PubMed ID: 34226572
[TBL] [Abstract][Full Text] [Related]
3. Oral Administration of Rhamnan Sulfate from
Terasawa M; Zang L; Hiramoto K; Shimada Y; Mitsunaka M; Uchida R; Nishiura K; Matsuda K; Nishimura N; Suzuki K
Cells; 2023 Nov; 12(22):. PubMed ID: 37998401
[TBL] [Abstract][Full Text] [Related]
4. Anti-Inflammatory Activity of Orally Administered
Terasawa M; Hiramoto K; Uchida R; Suzuki K
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200650
[TBL] [Abstract][Full Text] [Related]
5. Anti-Influenza A Virus Activity of Rhamnan Sulfate from Green Algae
Terasawa M; Hayashi K; Lee JB; Nishiura K; Matsuda K; Hayashi T; Kawahara T
Mar Drugs; 2020 May; 18(5):. PubMed ID: 32414158
[TBL] [Abstract][Full Text] [Related]
6. Biological Activities of Rhamnan Sulfate Extract from the Green Algae
Suzuki K; Terasawa M
Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32344720
[No Abstract] [Full Text] [Related]
7. Antidiabetic action of the Chinese formula Shouhuitongbian and the underlying mechanism associated with alteration of gut microbiota.
Wang T; Liao H; Lin J; Zhang M; Chen B; Yin R; Sun J; Dai H; Liu H
Phytomedicine; 2024 Jul; 129():155575. PubMed ID: 38636179
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals.
Benedict C; Vogel H; Jonas W; Woting A; Blaut M; Schürmann A; Cedernaes J
Mol Metab; 2016 Dec; 5(12):1175-1186. PubMed ID: 27900260
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota mediates the protective effects of dietary β-hydroxy-β-methylbutyrate (HMB) against obesity induced by high-fat diets.
Duan Y; Zhong Y; Xiao H; Zheng C; Song B; Wang W; Guo Q; Li Y; Han H; Gao J; Xu K; Li T; Yin Y; Li F; Yin J; Kong X
FASEB J; 2019 Sep; 33(9):10019-10033. PubMed ID: 31167080
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles.
Zhou R; He D; Zhang H; Xie J; Zhang S; Tian X; Zeng H; Qin Y; Huang L
J Ethnopharmacol; 2023 Mar; 303():115997. PubMed ID: 36509256
[TBL] [Abstract][Full Text] [Related]
11. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.
Lee JE; Lee SM; Jung J
Phytomedicine; 2020 Dec; 79():153354. PubMed ID: 32992082
[TBL] [Abstract][Full Text] [Related]
12. Dietary Advanced Glycation End Products Shift the Gut Microbiota Composition and Induce Insulin Resistance in Mice.
Wang J; Cai W; Yu J; Liu H; He S; Zhu L; Xu J
Diabetes Metab Syndr Obes; 2022; 15():427-437. PubMed ID: 35210793
[TBL] [Abstract][Full Text] [Related]
13. Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism.
Zhang L; Xie C; Nichols RG; Chan SH; Jiang C; Hao R; Smith PB; Cai J; Simons MN; Hatzakis E; Maranas CD; Gonzalez FJ; Patterson AD
mSystems; 2016; 1(5):. PubMed ID: 27822554
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
15. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
16. Propolis modulates the gut microbiota and improves the intestinal mucosal barrier function in diabetic rats.
Xue M; Liu Y; Xu H; Zhou Z; Ma Y; Sun T; Liu M; Zhang H; Liang H
Biomed Pharmacother; 2019 Oct; 118():109393. PubMed ID: 31545258
[TBL] [Abstract][Full Text] [Related]
17. Lingguizhugan decoction attenuates diet-induced obesity and hepatosteatosis
Liu MT; Huang YJ; Zhang TY; Tan LB; Lu XF; Qin J
World J Gastroenterol; 2019 Jul; 25(27):3590-3606. PubMed ID: 31367159
[TBL] [Abstract][Full Text] [Related]
18. Orlistat and ezetimibe could differently alleviate the high-fat diet-induced obesity phenotype by modulating the gut microbiota.
Jin J; Wang J; Cheng R; Ren Y; Miao Z; Luo Y; Zhou Q; Xue Y; Shen X; He F; Tian H
Front Microbiol; 2022; 13():908327. PubMed ID: 36046024
[TBL] [Abstract][Full Text] [Related]
19. Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice.
Lyu Y; Li D; Yuan X; Li Z; Zhang J; Ming X; Shaw PC; Zhang C; Kong APS; Zuo Z
Phytomedicine; 2022 Jul; 101():154099. PubMed ID: 35489323
[TBL] [Abstract][Full Text] [Related]
20. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
